The role of cortical cholinergic afferent projections in cognition: Impact of new selective immunotoxins

Behavioural Brain Research

Volumn 115, Issue 2, 2000, Pages 251-263

  McGaughy, J ^a   Everitt, B J ^a   Robbins, T W ^a   Sarter, M ^b  

^a UK   (United Kingdom)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

192 IgG saporin; Acetylcholine; Attention; Learning; Memory

Indexed keywords

ACETYLCHOLINE; EXCITOTOXIN; IMMUNOTOXIN; NEUROTOXIN;

ALZHEIMER DISEASE; ATTENTION; BRAIN CORTEX; CHOLINERGIC SYSTEM; COGNITION; FOREBRAIN; HUMAN; LEARNING; MEMORY; NERVE CELL DEGENERATION; NEUROPSYCHOLOGY; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; REVIEW;

EID: 0033796385     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(00)00262-X     Document Type: Article

References (95)

1. Aigner T., Mitchell S., Aggleton J., DeLong M., Struble P., Wenk G., Price D., Mishkin M. Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic acid lesions of the nucleus basalis of Meynert. Psychopharmacology. 92:1987;292-300.
2. Aigner T., Mitchell S., Aggleton J., DeLong M., Struble P., Price D., Wenk G., Pettigrew K.D., Mishkin M. Transient impairment in recognition memory following ibotenic acid induced lesions of the basal forebrain in macaques. Exp. Brain Res. 86:1991;18-26.
3. Arendt T., Bigl V., Tennstedt A., Arendt A. Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas. Neuroscience. 14:1985;1-11.
4. Baddeley A., Logie P., Bressi S., Della Sala S., Spinnler H. Dementia and working memory. Q. J. Exp. Psychol. 38A:1986;603-618.
5. Baxter M.G., Bucci D.J., Gorman L.K., Wiley R.G., Gallagher M. Selective immunotoxic lesions of basal forebrain cholinergic cells: effects on learning and memory in rats. Behav. Neurol. 109:1995;714-722.
6. Baxter M.G., Bucci D.J., Sobel T.J., Williams M.J., Gorman L.K., Gallagher M. Intact spatial learning following lesions of basal forebrain cholinergic neurons. Neuroreport. 7:1996;1417-1420.
7. Bigl V., Woolf N.J., Butcher L.L. Cholinergic projections from the basal forebrain to frontal, parietal, temporal, occipital and cingulate cortices: a combined fluorescent tracer and acetylcholinesterase analysis. Brain Res. Bull. 8:1982;727-749.
8. Book A.A., Wiley R.G., Schweitzer J.B. 192 IgG-saporin: I - specific lethality for cholinergic neurons in the basal forebrain of the rat. J. Neuropathol. Exp. Neurol. 53:1994;95-102.
9. Bowen D.M., Smith C.B., White P., Davison A.N. Neurotransmitter related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain. 99:1976;459-496.
10. Bucci D.J., Holland P.C., Gallagher M. Removal of cholinergic inputs to rat posterior parietal cortex disrupts incremental processing of conditioned stimuli. J. Neurosci. 18:1998;8038-8046.
11. Bussey T.J., Muir J.L., Everitt B.J., Robbins T.W. Dissociable effects of anterior and posterior cingulate cortex lesions on the acquisition of a conditional visual discrimination: facilitation of early learning versus an impairment in late learning. Behav. Brain Res. 82:1996;45-56.
12. Bussey T.J., Muir J.L., Everitt B.J., Robbins T.W. Triple dissociation of anterior cingulate, posterior cingulate, and medial frontal cortices on visual discrimination tasks using touchscreen testing procedure for the rat. Behav. Neuro. 111:1997;920-936.
13. Chiba A.A., Bucci D.J., Holland P.C., Gallagher M. Basal forebrain cholinergic lesions disrupt increments but not decrements in conditioned stimulus processing. J. Neurosci. 15:1995;7315-7322.
14. Curzon P., Bannon A.W., Decker M.W. Effect of 192 IgG-saporin injections into the nucleus basalis magnocellularis on acquisition and performance of a go/no-go procedure in the rat. Psychobiology. 27:1999;114-122.
15. Dornan W.A., McCampbell A.R., Tinkler G.P., Hickman U., Bannon A.W., Decker M.W., Gunther K.L. Comparison of site-specific injections into the basal forebrain on water maze and radial arm performance in the male rat after immunolesioning with 192 IgG-saporin. Behav. Brain Res. 82:1996;93-101.
16. Doughtery K.D., Salat D., Walsh T.J. Intraseptal injection of the cholinergic immunotoxin 192 IgG-saporin fails to disrupt latent inhibition in a conditioned taste aversion paradigm. Brain Res. 736:1996;260-269.
17. Dudchenko P., Sarter M. GABAergic control of basal forebrain cholinergic neurons and memory. Behav. Brain Res. 42:1991;202-205.
18. Dunnett S.B., Everitt B.J., Robbins T.W. The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions. Trends Neurosci. 14:1991;494-501.
19. Everitt B.J., Robbins T.W. Central cholinergic systems and cognition. Ann. Rev. Psychol. 48:1997;649-684.
20. Fadel J., Sarter M., Bruno J.P. Age-related attenuation of stimulated cortical acetylcholine release in basal forebrain lesioned rats. Neuroscience. 99:1999;793-802.
21. Fine A., Hoyle C., Maclean C.J., Levatte T.L., Baker H.F., Ridley R.M. Learning impairments following injection of a selective cholinergic immunotoxin, ME 20.4 IgG-saporin, into the basal nucleus of Meynert in monkeys. Neuroscience. 81:1997;331-343.
22. Gill, TM, Sarter M, Givens B. Sustained visual attentional performance-associated with prefrontal neuronal activity. Evidence for cholinergic modulation. J Neurosci, in press.
23. Granon S., Poucet B., Thinus-Blanc C., Changeux J.-P., Vidal C. Nicotinic and muscarinic receptors in the rat prefrontal cortex: differential roles in working memory, response selection and effortful processing. Psychopharmacology. 119:1995;139-144.
24. Greenwood P.M., Parasuraman R., Alexander G.E. Controlling the focus of spatial attention during visual search: effects of advanced aging and Alzheimer's disease. Neuropsychology. 11:1997;3-12.
25. Han J.-S., Holland P.C., Gallagher M. Disconnections of the amygdala central nucleus and substantia innominata/nucleus basalis disrupts increments in conditioned stimulus processing in rats. Behav. Neurosci. 117:1999;142-151.
26. Himmelheber A.M., Sarter M., Bruno J.P. Operant performance and cortical acetylcholine release: role of response rate, reward density and non-contingent stimuli. Cogn. Brain Res. 6:1997;23-36.
27. Himmelheber AM, Sarter M, Bruno JP. Increases in cortical acetylcholine release during sustained attention performance in rats. Cogn Brain Res, in press.
28. Hodges J.R., Patterson K. Is semantic memory consistently impaired early in the course of Alzheimer's disease? Neuroanatomical and diagnostic implications. Neuropsychologia. 33:1995;441-459.
29. Holley L.A., Wiley R.G., Lappi D.A., Sarter M. Cortical cholinergic deafferentation following the intracortical infusion of 192 IgG-saporin: a quantitative histochemical study. Brain Res. 663:1994;277-286.
30. Holley L.A., Turchi J., Apple C., Sarter M. Dissociation between the attentional effects of a benzodiazepine receptor agonist and an inverse agonist into the basal forebrain. Psychopharmacology. 120:1995;99-108.
31. Leanza G., Nilsson O.G., Nikkhah G., Wiley R.G., Bjorklund A. Effects of neonatal lesions of the basal forebrain cholinergic system by 192 immunoglobulin G-saporin: biochemical, behavioural and morphological characterization. Neuroscience. 74:1996;119-141.
32. Leanza G., Nilsson O.G., Nikkhah G., Wiley R.G. Bjorklund A. Selective lesioning of the basal forebrain cholinergic system by intraventricular 192 IgG-saporin: behavioural, biochemical, and stereological studies in the rat. Eur. J. Neurosci. 7:1995;329-343.
33. Lehericy S., Hirsch E.C., Cervera-Pierot P., Hersh L.B., Bakchine S., Piette F., Duyckaerts C., Hauw J.-J., Javoy-Agid F., Agid Y. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease. J. Comp. Neurol. 330:1993;15-31.
34. Marston H.M., West H.L., Wilkinson L.S., Everitt B.J., Robbins T.W. Effects of excitotoxic lesions of the septum and vertical limb of the nucleus of the diagonal band of Broca on conditional visual discrimination: relationship between performance and choline acetyltransferase activity in the cingulate cortex. J. Neurosci. 14:1994;2009-2019.
35. McAlonan G.M., Dawson G.R., Wilkinson L.S., Robbins T.W., Everitt B.J. The effects of AMPA-induced lesions of the medial septum and vertical limb nucleus of the diagonal band of Broca on spatial delayed non-matching to sample and spatial learning in the water maze. Eur. J. Neurosci. 7:1995;1034-1049.
36. McGaughy J., Sarter M. Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands. Psychopharmacology. 117:1995;340-357.
37. McGaughy J., Kaiser T., Sarter M. Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density. Behav. Neurosci. 110:1996;247-256.
38. McGaughy J., Sarter M. Sustained attention performance in rats with intracortical infusions of 192 IgG-saporin-induced cortical cholinergic deafferentation: effects of physostigmine and FG 7142. Behav. Neurosci. 112:1998;1519-1525.
39. McGaughy J., Decker M.W., Sarter M. Enhancement of sustained attention performance by the nicotinic acetylcholine receptor agonist ABT-418 in intact but not basal forebrain-lesioned rats. Psychopharmacology. 119:1999;175-182.
40. McGaughy J., Sarter M. Effects of ovariectomy, 192 IgG-saporin-induced cortical cholinergic deafferentation, and administration of estradiol on sustained attention performance in rats. Behav. Neuro. 113:1999;1-17.
41. Mesulam M.M., Mufson E.J., Levey A.I., Wainer B.H. Central cholinergic: pathways in the rat: an overview based on alternative nomenclature (Ch1-Ch6). Neuroscience. 10:1983;1185-1201.
42. Mesulam M.M., Mufson E.J., Levey A.I., Wainer B.H. Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata, and hypothalamus in the rhesus monkey. J. Comp. Neurol. 214:1983;170-197.
43. Miner L.A.H., Ostrander M., Sarter M. Effects of ibotenic acid-induced loss of neurons in the medial prefrontal cortex of rats on behavioral vigilance: evidence for executive dysfunction. J. Psychopharmacol. 11:1997;169-179.
44. Moore H.M., Sarter M., Bruno J.P. Bidirectional modulation of stimulated cortical acetylcholine release by benzodiazepine receptor ligands. Brain Res. 627:1993;267-274.
45. Morris R.G., Kopelman M.D. The memory deficits in Alzheimer-type dementia: a review. Q. J. Exp. Psychol. 38A:1986;575-602.
46. Muir J.L., Robbins T.W., Everitt B.J. Disruptive effects of muscimol infused into the basal forebrain on conditional discrimination and visual attention: differential interactions with cholinergic mechanisms. Psychopharmacology. 107:1992;541-550.
47. Muir J.L., Dunnett S.B., Robbins T.W., Everitt B.J. Attentional functions of the forebrain cholinergic systems: effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical grafts on a multiple-choice serial reaction time task. Exp. Brain Res. 89:1992;611-622.
48. Muir J.L., Everitt B.J., Robbins T.W. AMPA-induced excitotoxic lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function. J. Neurosci. 14:1994;2313-2326.
49. Muir J.L., Everitt B.J., Robbins T.W. Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron. Psychopharmacology. 118:1995;82-92.
50. Muir J.L., Everitt B.J., Robbins T.W. The cerebral cortex of the rat and visual attentional function: dissociable effects of mediofrontal, cingulate, anterior dorsolateral, and parietal cortex on a five-choice serial reaction time task. Cereb. Cortex. 6:1996;470-481.
51. Nissen M.J., Corkin S., Growdon M. Attentional focusing in patients with Alzheimer's disease. The Annual Conference of the American Aging Association, Chicago. 1981.
52. Ohtake T., Heckers S., Wiley R.G., Lappi D.A., Mesulam M.M., Geula C. Retrograde degeneration and colchicine protection of basal forebrain cholinergic neurons following hippocampal injections of an immunotoxin against the p75 nerve growth factor receptor. Neuroscience. 78:1997;123-133.
53. Parasuraman R., Giambra L. Skill development in vigilance: effects of event rate and age. Psychol. Aging. 6:1991;155-169.
54. Parasuraman P., Greenwood P.M., Haxby J.V., Grady C.L. Visuospatial attention in dementia of the Alzheimer type. Brain. 115:1992;711-733.
55. Parasuraman P., Haxby N. Attention and brain function in Alzheimer's disease: a review. Neuropsychology. 7:1993;242-272.
56. Perry E.K., Tomlinson B.E., Blessed G., Bergmann K., Gibson P.H., Perry R.H. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br. Med. J. 2:1978;1457-1459.
57. Perry E.K., Johnson M., Kerwin J.M., Piggott M.A., Court J.A., Shaw P.J., Ince P.G., Brown A., Perry R.H. Convergent cholinergic activities in aging and Alzheimer's disease. Neurobiol. Aging. 13:1992;393-400.
58. Perry R.J., Hodges J.R. Attention and executive deficits in Alzheimer's disease. Brain. 122:1999;383-404.
59. Ragozzino M.E., Kesner R.P. The effects of cholinergic receptor blockade in the rat anterior cingulate cortex and prelimbic/infralimbic cortices on spatial working memory. Neurobiol. Learn. Mem. 69:1998;241-257.
60. Ridley R.M., Aitken D.M., Baker H.F. Learning about rules but not reward is impaired following lesions of the cholinergic projections to the hippocampus. Brain Res. 502:1986;306-318.
61. Ridley R.M., Barefoot H.C., Maclean C.J., Pugh R., Baker H.F. Different effect on learning ability after injection of the cholinergic immunotoxin ME 20.4 IgG-saporin into the diagonal band of Broca, basal nucleus of Meynert or both in monkeys. Behav. Neurosci. 113:1999;303-315.
62. Robbins T.W., Everitt B.J., Ryan C.N., Marston H.M., Jones G.H., Page K.J. Comparative effects of quisqualic and ibotenic acid-induced lesions of the substantia innominata and globus pallidus on the acquisition of a conditional discrimination: differential effects on cholinergic mechanisms. Neuroscience. 28:1989;337-352.
63. Robbins T.W., James M., Owen A.M., Sahakian B.J., McInnes L., Rabbitt P. Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia. 5:1994;266-281.
64. Robbins T.W., Everitt B.J. Arousal systems and attention. Gazzaniga M.S. The Cognitive Neurosciences. 1995;703-720 MIT Press, Cambridge, MA.
65. Robbins T.W., Elliot R., Sahakian B.J. Neuropsychology - dementia and affective disorders. Br. Med. Bull. 52:1996;627-643.
66. Robbins T.W., McAlonan G., Muir J.L., Everitt B.J. Cognitive enhancers in theory and practice: studies of the cholinergic: hypothesis of cognitive deficits in Alzheimer's disease. Behav. Brain Res. 83:1997;15-23.
67. Roßner S. Cholinergic immunolesions by 192 IgG-saporin - a useful tool to simulate pathogenic aspects of Alzheimer's disease. Int. J. Dev. Neurosci. 15:1997;835-850.
68. Sahakian B., Jones G., Levy P., Gray J., Warburton D. The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br. J. Psychiatry. 154:1989;797-800. Comment in: Br J Psychiatry 1989;155:716.
69. Sahakian B.J., Jones G.M.M., Levy K., Gray J.A., Warburton D.M. The effects of nicotine on attention, information processing and short-term memory in patients with dementia of the Alzheimer's type. Br. J. Psychiatry. 154:1989;797-800.
70. Sahakian B.J., Downes J.J., Eagger S., Evenden J.L., Levy R., Philpot M.P., Roberts A.C., Robbins T.W. Sparing of attentional relative to mnemonic function in a subgroup of patients with dementia of the Alzheimer's type. Neuropsychologia. 28:1990;1197-1213.
71. Sahakian B.J., Owen A.M., Morant N.J., Eagger S.A., Boddington S., Crayton L., Crockford H.A., Crooks M., Hill Y., Levy R. Further analysis of the cognitive effects of tetrahydroacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB. Psychopharmacology. 110:1993;395-401.
72. Sahakian B.J., Coull J.T. Nicotine and tetrahyroaminoacridine: evidence for improved attention in patients with dementia of the Alzheimer's type. Drug Dev. Res. 31:1994;80-88.
73. Sarter M., Bruno J.P. Cognitive functions of cortical ACh (Acetylcholine): lessons from studies on the trans-synaptic modulation of activated efflux. Trends Neurosci. 17:1994;217-221.
74. Sarter M., Bruno J.P. Cognitive functions of cortical acetylcholine: toward a unifying hypothesis. Brain Res. Rev. 23:1997;28-46.
75. Sarter M., Bruno J.P. Abnormal regulation of corticopetal cholinergic neurons and impaired information processing in neuropsychiatric disorders. Trends Neurosci. 22:1999;67-74.
76. Schliebs R. Basal forebrain cholinergic dysfunction - experimental approaches and the diseased brain. Int. J. Dev. Neurosci. 16:1998;601-603.
77. Smith C.G., Beninger R.J., Mallet P.E., Jhamandas K., Boegman R.J. Basal forebrain injections of the benzodiazepine partial inverse agonist, FG 7142 enhance memory of rats in the double Y-maze. Brain Res. 666:1994;61-67.
78. Steckler T., Keith A.B., Wiley R.G., Sahgal A. Cholinergic lesions by 192 IgG-saporin and short-term recognition memory. role of the septohippocampal projection. Neuroscience. 66:1995;101-114.
79. Tang Y., Aigner T.G. Muscarinic receptor blockade in perirhinal cortex impairs visual recognition memory in monkeys. Soc. Neurosci. 22:1996;1750.
80. Thach W.T. What is the role of the cerebellum in motor learning and cognition. Trends Cogn. Sci. 2:1998;331-337.
81. Torres E.M., Perry T.A., Blokland A., Wilkinson L.S., Wiley R.G., Lappi D.A., Dunnett S.B. Behavioral, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system. Neuroscience. 63:1994;95-122.
82. Townshend J., Courchesne E., Covington J., Westerfield M., Harris N.S., Lyden P., Lowry T.P., Press G.A. Spatial attention deficits in patients with acquired or developmental cerebellar abnormality. J. Neurosci. 19:1999;5632-5643.
83. Turchi J., Sarter M. Cortical acetylcholine and processing capacity: effects of cortical cholinergic deafferentation on crossmodal divided attention in rats. Cogn. Brain Res. 6:1997;147-158.
84. Voytko M.L., Olton D.S., Richardson R.T., Gorman L.K., Tobin J.R., Price M. Basal forebrain lesions in monkeys disrupt attention but not learning and memory. J. Neurosci. 14:1994;167-186.
85. Waite J.J., Chen A.D., Wardlow M.L., Wiley R.G., Lappi D.A., Thal L.J. 192 Immunoglobulin G-saporin produces graded behavioral and biochemical changes accompanying the loss of cholinergic neurons of the basal forebrain and cerebellar purkinje cells. Neuroscience. 65:1995;463-476.
86. Waite J.J., Thal L.J. Lesions of the cholinergic nuclei in the rat basal forebrain: excitotoxins vs. an immunotoxin. Life Sci. 58:1996;1947-1953.
87. Waite J.J., Wardlow M.L., Power A.E. Deficit in selective and divided attention associated with the cholinergic basal forebrain immunotoxic lesion produced by 192 IgG-saporin; motoric/sensory deficit associated with purkinje cell immunotoxic lesion produced by OX7-saporin. Neurobiol. Learn. Mem. 71:1999;325-352.
88. Walsh U., Herzog C.D., Gandhi C., Stackman R.W., Wiley R.G. Injection of 192 IgG-saporin into the medial septum produces cholinergic hypofunction and dose-dependent working memory deficits. Brain Res. 726:1996;69-79.
89. Wenk G.L., Willard L.B. The neural mechanisms underlying cholinergic cell death within the basal forebrain. Int. J. Dev. Neurosci. 16:1998;729-735.
90. Whishaw I.Q., O'Connor W.T., Dunnett S.B. Disruption of central cholinergic systems in the rat by basal forebrain lesions or atropine: effects on feeding, sensorimotor behaviour, locomotor activity and spatial navigation. Behav. Brain Res. 17:1985;103-115.
91. Whitehouse P.J., Price D.L., Clark A.W., Coyle J.T., DeLong M.R. Alzheimer's disease evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann. Neurol. 10:1981;122-126.
92. Whitehouse P.J., Price D.L., Struble R.G., Clark A.W., Coyle J.T., DeLong M.R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science. 215:1982;2137-2139.
93. Wiley R.G., Berbos T.G., Deckwerth T., Johnson E.M., Lappi D.A. Destruction of the cholinergic basal forebrain using immunotoxin to rat NGF receptor: modeling the cholinergic degeneration of Alzheimer's disease. J. Neurol. Sci. 128:1995;157-166.
94. Woolf N.J. A possible role for cholinergic neurons of the basal forebrain and pontomesencephalon in consciousness. Consciousness Cogn. 6:1997;574-596.
95. Wrenn C.C., Lappi D.A., Wiley R.G. Threshold relationship between the lesion extent of cholinergic basal forebrain in the rat and working memory impairment in the radial maze. Brain Res. 847:1999;284-298.